STAND. COM. REP. NO.  344-18

 

Honolulu, Hawaii

                , 2018

 

RE:   H.B. No. 2631

      H.D. 1

 

 

 

 

Honorable Scott K. Saiki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

 

Sir:

 

     Your Committee on Health & Human Services, to which was referred H.B. No. 2631 entitled:

 

"A BILL FOR AN ACT RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM,"

 

begs leave to report as follows:

 

     The purpose of this measure is to make use of data available within the Electronic Prescription Accountability System to inform prescribers of the percentile ranking of their opioid prescription rates in relation to their peers.  

 

     Two individuals supported this measure.  The Department of Public Safety provided comments.  

 

     Your Committee notes that concerns were raised by the Department of Public Safety (Department) in its testimony that additional costs may be incurred by the Department to carry out the provisions of this measure.  The Department notes that its Narcotics Enforcement Division's Prescription Drug Monitoring Program requires an enhancement to annually determine the mean and median quantity and volume of prescriptions for opiates.  The Department further notes that Narcotics Enforcement Division's controlled substances registration system requires enhancements to report data with regard to "practitioners of a similar specialty or practice type" and to collect data to identify a prescriber's specialty or practice type.

 

     Your Committee has amended this measure by changing its effective date to July 1, 3000, to encourage further discussion.

 

     As affirmed by the record of votes of the members of your Committee on Health & Human Services that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2631, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 2631, H.D. 1, and be referred to your Committee on Consumer Protection & Commerce.

 

 

Respectfully submitted on behalf of the members of the Committee on Health & Human Services,

 

 

 

 

____________________________

JOHN M. MIZUNO, Chair